The first #LpAHORIZON results have been announced, but the complete data are still to come. Don't jump to conclusions. 👉 Read the full statement about the announcement from @lpa-taskforce.org: shorturl.at/6jSBt #KnowYourLpa #Lipoproteina #CardiovascularHealth

BREAKING! The new EAS Consensus Statement on FH in children and adolescents has just been published! Presented at the #EAS26 congress in Athens, led by FHEF Trustee and Chair of the Scientific Advisory Committee Prof. Albert Wiegman, together with Prof. Jeanine Roeters van Lennep.

At #EAS2026, Prof. @zanfinaa.bsky.social Ademi showed Lp(a)-lowering therapies could be cost‑effective, especially for secondary prevention. Using UK Biobank data, the analysis highlights strong potential for earlier intervention, smarter pricing & better CVD outcomes.

🚨 Breaking News from #EAS2026 🚨 Today, @eassociety.bsky.social launches a landmark new global consensus statement on: “Lipid clinics worldwide: harmonisation and guidance on how to optimally organise and fund”. Proud that our Ambassador Programme Manager, Elsie Evans, is among the paper’s co-authors

This week, FHEF officially submitted its response to the EC’s Call for Evidence on Cardiovascular Health Checks. Read our submission: shorturl.at/4Af45 Huge thanks to our network for mobilising around early detection & prevention. Together, we are making our voice stronger. Prevent the Preventable.

Guess who won the afternoon quiz at #WorldHeartSummit? 🫀🏆 Our Scientific Communication Manager, Marina C. Leroy, PhD 👏 A brilliant win among leading heart health experts from around the world 🌍 Science communication skills + sharp minds = success ❤️🧠 Congratulations to Marina!

At #WorldHeartSummit 2026, experts stressed a clear message: prevention must come first. Medical innovation alone won’t reduce cardiovascular disease without healthier food systems, stronger public health policy, nutrition education, and prevention programmes. #HeartHealth